Sonia Sequeira

Title: The Innovative Contributions of Sonia Sequeira

Introduction

Sonia Sequeira is a prominent inventor based in Verona, NJ (US), known for her significant contributions to the field of medical therapeutics. With a total of two patents to her name, she has made strides in addressing critical health challenges through her innovative research.

Latest Patents

Sonia's latest patents include groundbreaking work on fusion proteins for the diagnosis, prophylaxis, and treatment of infectious diseases. This invention focuses on the use of phosphatidylserine or pathogenic sugar-targeted therapeutics for managing and treating microbial infections, including Zika, Dengue, West Nile, Ebola, H1N1, enteroviruses, Leishmaniasis, Malaria, and Coronaviruses such as SARS-COV. Additionally, she has developed CD3/CD25 antibodies for neuro-immune diseases, which relates to the use of anti-CD3 and anti-CD25 antibodies for managing and treating inflammatory diseases and psycho-immune disorders, such as depression, autism (ASD), and attention deficit/hyperactivity disorder (ADHD).

Career Highlights

Sonia Sequeira has established herself as a key figure in her field, working with Vitruviae LLC, where she continues to push the boundaries of medical research and innovation. Her work has the potential to transform treatment protocols for various infectious and neuro-immune diseases.

Collaborations

Sonia collaborates with Mahiuddin Ahmed, contributing to the advancement of their shared goals in medical research and innovation.

Conclusion

Sonia Sequeira's innovative work and dedication to addressing complex health issues through her patents exemplify her commitment to improving medical treatments. Her contributions are paving the way for future advancements in the field.